Hypertension and hepatic steatosis.

Research output: Contribution to journalArticle

2 Citations (Scopus)


Hepatic steatosis (fatty liver) is increasingly recognized as a major component of the metabolic (insulin resistance) syndrome. It can progress to cirrhosis and hepatocellular carcinoma, leading to liver-related mortality. Increasing evidence shows a significant association between hepatic steatosis and hypertension; both are linked to the metabolic syndrome. This review discusses the evidence to support this association, and reviews the diagnosis and management of hepatic steatosis.
Original languageEnglish
Pages (from-to)182-7
Number of pages6
JournalCurrent hypertension reports
Issue number3
Publication statusPublished - 1 Jun 2008


Dive into the research topics of 'Hypertension and hepatic steatosis.'. Together they form a unique fingerprint.

Cite this